Christopher Brooke
Operationeel Directeur bij SwanBio Therapeutics, Inc.
Vermogen: 165 734 $ op 30-04-2024
Actieve functies van Christopher Brooke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Operationeel Directeur | 16-10-2023 | - |
Loopbaan van Christopher Brooke
Eerdere bekende functies van Christopher Brooke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AYTU BIOPHARMA, INC. | Operationeel Directeur | 14-11-2022 | 13-10-2023 |
| Corporate Officer/Principal | 01-04-2021 | 14-11-2022 | |
| Rumpus Therapeutics | Oprichter | - | - |
Opleiding van Christopher Brooke
| Colgate University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Rumpus Therapeutics |
- Beurs
- Insiders
- Christopher Brooke
- Ervaring
